Lori Anne Kunkel - 31 Jan 2022 Form 4 Insider Report for CURIS INC (CRIS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
31 Jan 2022, 16:33:15 UTC
Prior SEC filing
17 Jun 2021
Next SEC filing
06 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ William Steinkrauss, Attorney-in-fact

Key filing fact

Lori Anne Kunkel filed Form 4 for CURIS INC (CRIS) on 31 Jan 2022.

Key facts

  • This page summarizes Lori Anne Kunkel's Form 4 filing for CURIS INC (CRIS).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 31 Jan 2022, 16:33.

Change

  • Previous filing in this sequence was filed on 17 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRIS transaction Derivative

Non Qualified Stock Option

Award

Transaction value
$0
Shares
+85,000
Change %
Price
$0.000000
Shares after
85,000
Date
31 Jan 2022
Ownership
Direct
Underlying class
Common stock
Underlying amount
85,000
Exercise price
$3.19
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 31, 2023), subject to the director's continued service with the Company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .